Karun D. Naga

Karun is an operating executive and entrepreneur in the healthcare industry. As part of The Foundry’s leadership, Karun has led the formation and incubation of several new ventures, including Foundry Therapeutics, a platform for localized, sustained drug delivery, Allay Therapeutics, a clinical-stage company focused on durable, opioid-free pain control following major surgery, and Foundry Therapeutics 2, a collaboration addressing unmet needs in China.

Prior to joining The Foundry, Karun was part of the executive team at Altura Medical, a venture-funded startup that developed a breakthrough endograft for treating abdominal aortic aneurysm and was acquired by Lombard Medical. Prior to joining Altura Medical, Karun was Director of Corporate Development at Medtronic, where he had roles in business development, strategic partnering, and corporate investment across Medtronic’s cardiovascular portfolio. Karun joined Medtronic via its acquisition of Ardian, a Foundry portfolio company that pioneered a catheter-based treatment for hypertension, where he served on its executive management team. In a previous stint with The Foundry, Karun served on the founding team of Miramar Labs, a dermatology and aesthetics medicine company. Karun also previously worked at Mentor Corporation, as its first in-house intellectual property counsel, and Jones Day, a leading international law firm.

Karun serves on the boards of directors of Foundry Therapeutics, Allay Therapeutics, Foundry Therapeutics 2, and Foundry Endovascular and is also a patent attorney registered with the US Patent Office. Karun holds a BS in mechanical engineering from Michigan State University, a JD from the University of Michigan Law School, and an MBA from The Wharton School of The University of Pennsylvania.